Earnings NewsHealthcareInsys Therapeutics beats by $0.02, beats on revenueNov. 11, 2014 7:05 AM ETINSYS Therapeutics, Inc. (INSYQ) StockBy: SA News Team Insys Therapeutics (INSY): Q3 EPS of $0.31 beats by $0.02; Non-GAAP EPS of $0.63. Revenue of $58.28M (+99.5% Y/Y) beats by $1.2M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgINSYQ--INSYS Therapeutics, Inc.Trending AnalysisTrending News